Mutations and localization of TRPM4 mutations (A ). Electrophoregrams of 3 mutations. W for A/T heterozygosity, and Y for C/T. (D): Localization of TRPM4 mutations resulting in conduction blocks (yellow), Brugada syndrome (blue) or both (green). doi:10.1371/journal.pone.0054131.gsignificantly increased for p.Pro779Arg compared to WT, while other mutants did not exhibited significant changes. Activation time. Activation time of the current was determined using a pulse protocol from Vm = 0 to +80 mV (figure S1 A). No significant differences were seen between mutants and WT (figure S1 B). Channel expression was evaluated in the inside-out configuration by estimating the maximal number of channels opened at Vm = +40 mV with 1023 M [Ca2+]i. As shown in figure S2, it was observed a significant decrease in the number of active channels for p.Pro779Arg compared to WT and as mentioned before, no active channels were detected for p.Lys914X. Other mutants did not shown significant variation with WT.Total and cell surface expression of TRPM4 mutant channels. To test whether the BrS mutations altered the Channel configuration. detection in the inside-outthe core glycosylated form (lower band) of total and surface expressions whereas the p.Leu1075Pro had a significant surface expression increase.DiscussionHere, we present a series of genetic variants found in a large cohort of spontaneous or drug-challenged type 1 BrS patients. Among the 14 TRPM4 variants, 3 were considered as polymorphisms. By contrast, the 11 remaining variants are presumably Fingolimod (hydrochloride) pathogenic mutations. Among these 11 mutations, 5 are totally absent from the very large control cohorts (more than 6 500 individuals), whereas 4 others have a statistically higher prevalence in the BrS cohort than in the control cohorts. As an EW-7197 biological activity autosomal condition with incomplete penetrance, it is not surprising that genetic variants resulting in BrS or predisposing to BrS might be found in large control cohorts. It is important to note that the size of the BrS and control cohorts allow us to use statistical tests to assess a difference of variant prevalence between both groups. The 1655472 variants p.A432T and p.G844D were previously found in families with autosomal dominant cardiac conduction blocks [16]. None of the mutation carriers in the conduction block families had (even retrospectively) an ECG suggestive of a BrS [16]. Interestingly, in this series of 20 BrS cases with TRPM4 mutations or predisposing factors, 18 patients had a conduction block. The 2 patients with no widening of QRS had a rSr’ complex. This observation suggests that TRPM4 mutation screening should be considered in BrS when a widening of QRS or a rSr’ complex is observed, a condition which not rare in BrS cases. Similar to the families with cardiac conduction blocks, no cases of left bundle branch block were observed.cellular and cell surface expression level of TRPM4 channels, WT and TRPM4 mutants were transiently transfected in HEK293 cells. Forty-eight hours post-transfection, the expression of TRPM4 channels at the total protein level and at the cell surface was assessed by quantitative Western blots (figure 6 and figure S3). Under our migration conditions, two distinct bands representing fully and core glycosylated forms of TRPM4 were observed. All mutants showed a significantly altered expression of TRPM4. The p.Pro779Arg and p.Lys914X mutants showed a decreased of total expression whereas p.Lys914X was comparable to background level. W.Mutations and localization of TRPM4 mutations (A ). Electrophoregrams of 3 mutations. W for A/T heterozygosity, and Y for C/T. (D): Localization of TRPM4 mutations resulting in conduction blocks (yellow), Brugada syndrome (blue) or both (green). doi:10.1371/journal.pone.0054131.gsignificantly increased for p.Pro779Arg compared to WT, while other mutants did not exhibited significant changes. Activation time. Activation time of the current was determined using a pulse protocol from Vm = 0 to +80 mV (figure S1 A). No significant differences were seen between mutants and WT (figure S1 B). Channel expression was evaluated in the inside-out configuration by estimating the maximal number of channels opened at Vm = +40 mV with 1023 M [Ca2+]i. As shown in figure S2, it was observed a significant decrease in the number of active channels for p.Pro779Arg compared to WT and as mentioned before, no active channels were detected for p.Lys914X. Other mutants did not shown significant variation with WT.Total and cell surface expression of TRPM4 mutant channels. To test whether the BrS mutations altered the Channel configuration. detection in the inside-outthe core glycosylated form (lower band) of total and surface expressions whereas the p.Leu1075Pro had a significant surface expression increase.DiscussionHere, we present a series of genetic variants found in a large cohort of spontaneous or drug-challenged type 1 BrS patients. Among the 14 TRPM4 variants, 3 were considered as polymorphisms. By contrast, the 11 remaining variants are presumably pathogenic mutations. Among these 11 mutations, 5 are totally absent from the very large control cohorts (more than 6 500 individuals), whereas 4 others have a statistically higher prevalence in the BrS cohort than in the control cohorts. As an autosomal condition with incomplete penetrance, it is not surprising that genetic variants resulting in BrS or predisposing to BrS might be found in large control cohorts. It is important to note that the size of the BrS and control cohorts allow us to use statistical tests to assess a difference of variant prevalence between both groups. The 1655472 variants p.A432T and p.G844D were previously found in families with autosomal dominant cardiac conduction blocks [16]. None of the mutation carriers in the conduction block families had (even retrospectively) an ECG suggestive of a BrS [16]. Interestingly, in this series of 20 BrS cases with TRPM4 mutations or predisposing factors, 18 patients had a conduction block. The 2 patients with no widening of QRS had a rSr’ complex. This observation suggests that TRPM4 mutation screening should be considered in BrS when a widening of QRS or a rSr’ complex is observed, a condition which not rare in BrS cases. Similar to the families with cardiac conduction blocks, no cases of left bundle branch block were observed.cellular and cell surface expression level of TRPM4 channels, WT and TRPM4 mutants were transiently transfected in HEK293 cells. Forty-eight hours post-transfection, the expression of TRPM4 channels at the total protein level and at the cell surface was assessed by quantitative Western blots (figure 6 and figure S3). Under our migration conditions, two distinct bands representing fully and core glycosylated forms of TRPM4 were observed. All mutants showed a significantly altered expression of TRPM4. The p.Pro779Arg and p.Lys914X mutants showed a decreased of total expression whereas p.Lys914X was comparable to background level. W.